Robaxin and Adcirca drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Robaxin (methocarbamol) and Adcirca (tadalafil). Common drug interactions include confusional state among females.
The phase IV clinical study analyzes what interactions people have when they take Robaxin and Adcirca. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.
What is Robaxin?
Robaxin has active ingredients of methocarbamol. It is often used in muscle spasms. eHealthMe is studying from 9,109 Robaxin users. Check the latest studies of Robaxin.
What is Adcirca?
Adcirca has active ingredients of tadalafil. It is often used in pulmonary hypertension. eHealthMe is studying from 54,957 Adcirca users. Check the latest studies of Adcirca.
15 people who take Robaxin and Adcirca together, and have interactions are studied.

What are the common drug interactions of Robaxin and Adcirca, by gender? *:
female:
- Confusional state
- Headache (pain in head)
- Epistaxis (bleed from the nose)
- Feeling hot
- Fungal infection
- Hunger
- Hyperhidrosis (abnormally increased sweating)
- Hypoglycaemia (deficiency of glucose in the bloodstream)
- Infection
- Loss of consciousness
male:
n/a
What are the common drug interactions of Robaxin and Adcirca, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Confusional state
- Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
- Somnolence (a state of near-sleep, a strong desire for sleep)
- Abdominal pain
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Nausea (feeling of having an urge to vomit)
- Septic shock (shock due to blood infection)
- Vomiting
- Cardiac failure acute
- Cerebral infarction (less blood supply to brain resulting tissue damage)
40-49:
- Headache (pain in head)
- Cardiomegaly (increased size of heart than normal)
- Feeling hot
- Fungal infection
- Hunger
- Hyperhidrosis (abnormally increased sweating)
- Hypoglycaemia (deficiency of glucose in the bloodstream)
- Infection
- Loss of consciousness
- Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
50-59:
- Gastric cancer (stomach cancer)
- Gastric polyps (abnormal growth of stomach tissue projecting from a mucous membrane)
60+:
- Decreased appetite
- Epistaxis (bleed from the nose)
- Blood alkaline phosphatase increased
- Confusional state
- Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
- Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
- Hepatic enzyme increased
- Insomnia (sleeplessness)
- International normalised ratio increased
- Pain in jaw
What are the existing conditions these people have? *
- Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 9 people, 60.00%
- Stress And Anxiety: 3 people, 20.00%
- Nausea And Vomiting: 3 people, 20.00%
- Nausea (feeling of having an urge to vomit): 3 people, 20.00%
- Diarrhea: 3 people, 20.00%
- Systemic Sclerosis (Scleroderma) (an autoimmune or connective tissue disease. it is characterized by thickening of the skin): 2 people, 13.33%
- Pain: 2 people, 13.33%
- Swelling: 1 person, 6.67%
- Subdural Haematoma (blood collects between the skull and the surface of the brain): 1 person, 6.67%
- Dyspnea (difficult or laboured breathing): 1 person, 6.67%
* Approximation only. Some reports may have incomplete information.
Do you take Robaxin and Adcirca?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Robaxin and Adcirca:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Robaxin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Adcirca:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Robaxin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Adcirca and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on methocarbamol and tadalafil (the active ingredients of Robaxin and Adcirca, respectively), and Robaxin and Adcirca (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Weight Loss in Neurontin, how severe and when it was recovered? - 13 seconds ago
- Topamax and Ventilatory Failure for Women aged 50-59 - 20 seconds ago
- Topamax and Respiratory Failure for Women aged 50-59 - 20 seconds ago
- Topamax and Acidosis - Respiratory for Women aged 50-59 - 20 seconds ago
- Topamax and Respiratory Acidosis for Women aged 50-59 - 21 seconds ago
- Sinusitis and Encephalitis - 27 seconds ago
- Clarithromycin and Lysine drug interactions for women aged 60+ - 29 seconds ago
- Muscle Function Loss and drugs of ingredients of sulfasalazine - 31 seconds ago
- Ciprofloxacin Extended Release vs. Zithromax, side effect and effectiveness comparison - 43 seconds ago
- Clopra and Hydramine drug interactions for men aged 50-59 - 43 seconds ago